
Retatrutide
Starting at $449/mo — Includes Script & Telemedicine Consultation
Peptides are dispensed by prescription only. Complete a consultation with our practitioner to confirm eligibility and unlock purchasing.
The Science
Retatrutide is a triple receptor agonist hitting GLP-1, GIP, and glucagon simultaneously, producing weight loss results that dwarf both semaglutide and tirzepatide. Clinical trial participants lost an average of 24% of their body weight.
Key Benefits
- Triple GLP-1/GIP/glucagon receptor activation
- Clinical trials show average 24% body weight reduction at 48 weeks
- Superior fat loss outcomes compared to semaglutide and tirzepatide
- Suppresses appetite, increases energy expenditure, and accelerates fat oxidation
- Nicole's top recommendation for clients who want maximum metabolic results
Reviews
Write a Review
No reviews yet. Be the first!